Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Essence (BIOE) EBITDA (2020 - 2025)

Historic EBITDA for Bio Essence (BIOE) over the last 6 years, with Q3 2025 value amounting to $14253.0.

  • Bio Essence's EBITDA rose 10973.25% to $14253.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$125764.0, marking a year-over-year increase of 8090.91%. This contributed to the annual value of -$459438.0 for FY2024, which is 3294.31% down from last year.
  • Latest data reveals that Bio Essence reported EBITDA of $14253.0 as of Q3 2025, which was up 10973.25% from $61223.0 recorded in Q2 2025.
  • In the past 5 years, Bio Essence's EBITDA registered a high of $63759.0 during Q4 2022, and its lowest value of -$261295.0 during Q2 2021.
  • Its 5-year average for EBITDA is -$121226.8, with a median of -$155895.0 in 2022.
  • Per our database at Business Quant, Bio Essence's EBITDA crashed by 52454.96% in 2024 and then skyrocketed by 13710.19% in 2025.
  • Over the past 5 years, Bio Essence's EBITDA (Quarter) stood at -$198769.0 in 2021, then soared by 132.08% to $63759.0 in 2022, then plummeted by 406.59% to -$195476.0 in 2023, then skyrocketed by 101.97% to $3852.0 in 2024, then surged by 270.02% to $14253.0 in 2025.
  • Its last three reported values are $14253.0 in Q3 2025, $61223.0 for Q2 2025, and -$205092.0 during Q1 2025.